Swiss-Canadian vaccine to be tested on mice in Geneva
A joint Swiss-Canadian coronavirus vaccine is due to be tested on mice in Geneva. If the tests go well, clinical trials will be launched at the Geneva University Hospital.
It should take about six weeks for the results of the first stage to be known.
A doctor heading the research, Nicolas Mach, says it could be tested on people early next year.
The vaccine is being developed jointly by the University of Geneva and Laval University in Quebec.